Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939883A discloses a metal-free visible light catalyzed method for polysubstituted 1,3-oxazolidines. High yield, mild conditions, cost-effective for pharma intermediates.
Novel synthesis route for desvenlafaxine succinate offering high purity and cost reduction for pharmaceutical supply chains ensuring reliable global availability and quality.
Patent CN118147114A reveals beta-glucosidase mutant for phloretin. Enables cost reduction in flavonoid manufacturing and reliable supply chain scalability.
Patent CN110951799B details a novel whole-cell enzymatic route for high-purity antibiotic intermediates, offering significant cost reduction and scalable manufacturing advantages.
Novel patent CN115536563B reveals elemental sulfur route. Reduces cost and toxicity for high-purity thiourea manufacturing. Reliable supply chain partner.
Patent CN101391982B details a safe, high-yield alkylation method for benzimidazoles using phase transfer catalysis, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel aqueous phase transfer catalysis method for high-purity 3-ethoxy-4-methoxybenzaldehyde, offering green synthesis and cost efficiency for API manufacturing.
Patent CN106146359B reveals metal-free amide synthesis. Discover cost reduction in peptide manufacturing and high-purity intermediate supply chain solutions.
New patent CN116332889B reveals high-yield BTDA route. Enhances supply chain stability and reduces manufacturing costs for polyimide producers globally.
Patent CN115109769B reveals L-threonine aldolase mutants enabling >99% conversion for L-serine synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN105016984B reveals a scalable synthesis for Tamsulosin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with mild conditions.
Novel side-arm ferrocene ligands enable efficient asymmetric cyclopropanation for pyrethroid production with high yield and selectivity.
Patent CN103667397B details enzymatic synthesis for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN106380398A reveals a green esterification route eliminating thionyl chloride. This method ensures high purity, reduced waste, and reliable supply chain continuity.
Patent CN101440065A reveals a solvent-free ball milling route for pyrazolines, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN107721853A reveals enzymatic synthesis for latamoxef side chain. High purity, green process, cost reduction in pharma intermediate manufacturing.
Patent CN1302116C reveals a novel enzymatic route for high-purity cyclopentene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN109097409A reveals dual-product enzymatic route. High purity D-amino acids and alpha keto acids. Cost-effective supply chain solutions for global pharmaceutical manufacturing.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.